FI963313A - TCF-mutant - Google Patents
TCF-mutant Download PDFInfo
- Publication number
- FI963313A FI963313A FI963313A FI963313A FI963313A FI 963313 A FI963313 A FI 963313A FI 963313 A FI963313 A FI 963313A FI 963313 A FI963313 A FI 963313A FI 963313 A FI963313 A FI 963313A
- Authority
- FI
- Finland
- Prior art keywords
- tcf
- amino acid
- present
- mutant
- activity
- Prior art date
Links
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 238000002703 mutagenesis Methods 0.000 abstract 1
- 231100000350 mutagenesis Toxicity 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33788594 | 1994-12-27 | ||
| JP33788594 | 1994-12-27 | ||
| JP9502708 | 1995-12-27 | ||
| PCT/JP1995/002708 WO1996020214A1 (fr) | 1994-12-27 | 1995-12-27 | Mutant de tcf |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI963313A0 FI963313A0 (sv) | 1996-08-26 |
| FI963313A true FI963313A (sv) | 1996-08-26 |
| FI116223B FI116223B (sv) | 2005-10-14 |
Family
ID=18312917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963313A FI116223B (sv) | 1994-12-27 | 1996-08-26 | TCF-mutant |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6399744B1 (sv) |
| EP (2) | EP0757994B1 (sv) |
| JP (1) | JP3699482B2 (sv) |
| KR (1) | KR100294328B1 (sv) |
| AT (1) | ATE248913T1 (sv) |
| AU (1) | AU698221B2 (sv) |
| CA (1) | CA2183856C (sv) |
| DE (1) | DE69531673T2 (sv) |
| DK (1) | DK0757994T3 (sv) |
| ES (1) | ES2206523T3 (sv) |
| FI (1) | FI116223B (sv) |
| HU (1) | HU220167B (sv) |
| NO (1) | NO319022B1 (sv) |
| NZ (1) | NZ298142A (sv) |
| WO (1) | WO1996020214A1 (sv) |
| ZA (1) | ZA9510982B (sv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3699482B2 (ja) * | 1994-12-27 | 2005-09-28 | 第一製薬株式会社 | Ｔｃｆ変異体 |
| JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び／又は治療剤 |
| CA2253629A1 (en) | 1997-03-14 | 1998-09-24 | Snow Brand Milk Products Co., Ltd. | Agent for preventing and/or treating cachexia |
| KR100552434B1 (ko) * | 1997-03-28 | 2006-05-16 | 다이이치세이야꾸 가부시끼가이샤 | 신질환 예방 및/또는 치료제_ |
| JP3961064B2 (ja) * | 1997-03-28 | 2007-08-15 | 第一製薬株式会社 | 腎疾患予防及び／又は治療剤 |
| GB9709453D0 (en) * | 1997-05-10 | 1997-07-02 | Imp Cancer Res Tech | Polypedtides and their use in therapy |
| DE19909251A1 (de) | 1998-02-21 | 1999-08-26 | Max Delbrueck Centrum | Mittel zur Therapie von menschlichen Erkrankungen, ausgehend von beta-Catenin, seine Herstellung und seine Verwendung |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
| EP0539590B1 (en) * | 1990-07-13 | 1999-03-31 | Snow Brand Milk Products Co., Ltd. | Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same |
| ES2181689T3 (es) * | 1992-05-18 | 2003-03-01 | Genentech Inc | Variantes del factor de crecimiento de hepatocitos. |
| KR100260964B1 (ko) * | 1992-07-16 | 2000-07-01 | 쇼노 카츄야 | Tcf-ii를 유효성분으로 하는 혈액응고 정상화제 |
| HUT68170A (en) * | 1992-12-28 | 1995-03-21 | Snow Brand Milk Products Co Ltd | Modified tumor cytotoxic factor /tcf/ |
| JP3699482B2 (ja) * | 1994-12-27 | 2005-09-28 | 第一製薬株式会社 | Ｔｃｆ変異体 |
| JP3961064B2 (ja) * | 1997-03-28 | 2007-08-15 | 第一製薬株式会社 | 腎疾患予防及び／又は治療剤 |
| JPH1129493A (ja) * | 1997-07-14 | 1999-02-02 | Snow Brand Milk Prod Co Ltd | 放射線障害予防及び／又は治療剤 |
-
1995
- 1995-12-27 JP JP52036596A patent/JP3699482B2/ja not_active Expired - Lifetime
- 1995-12-27 WO PCT/JP1995/002708 patent/WO1996020214A1/ja active IP Right Grant
- 1995-12-27 EP EP95942271A patent/EP0757994B1/en not_active Expired - Lifetime
- 1995-12-27 AT AT95942271T patent/ATE248913T1/de not_active IP Right Cessation
- 1995-12-27 EP EP02077639A patent/EP1275718A3/en not_active Withdrawn
- 1995-12-27 US US08/700,519 patent/US6399744B1/en not_active Expired - Fee Related
- 1995-12-27 HU HU9602174A patent/HU220167B/hu not_active IP Right Cessation
- 1995-12-27 NZ NZ298142A patent/NZ298142A/xx not_active IP Right Cessation
- 1995-12-27 KR KR1019960704673A patent/KR100294328B1/ko not_active IP Right Cessation
- 1995-12-27 CA CA002183856A patent/CA2183856C/en not_active Expired - Fee Related
- 1995-12-27 DE DE69531673T patent/DE69531673T2/de not_active Expired - Fee Related
- 1995-12-27 DK DK95942271T patent/DK0757994T3/da active
- 1995-12-27 ZA ZA9510982A patent/ZA9510982B/xx unknown
- 1995-12-27 ES ES95942271T patent/ES2206523T3/es not_active Expired - Lifetime
- 1995-12-27 AU AU43551/96A patent/AU698221B2/en not_active Ceased
-
1996
- 1996-08-26 NO NO19963552A patent/NO319022B1/no not_active IP Right Cessation
- 1996-08-26 FI FI963313A patent/FI116223B/sv active IP Right Grant
-
2002
- 2002-04-25 US US10/133,912 patent/US20020165358A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO963552L (no) | 1996-10-28 |
| EP1275718A3 (en) | 2003-03-19 |
| FI116223B (sv) | 2005-10-14 |
| CA2183856A1 (en) | 1996-06-28 |
| WO1996020214A1 (fr) | 1996-07-04 |
| EP0757994A4 (en) | 1998-10-21 |
| AU698221B2 (en) | 1998-10-29 |
| ATE248913T1 (de) | 2003-09-15 |
| CA2183856C (en) | 2006-11-07 |
| DE69531673T2 (de) | 2004-07-08 |
| EP0757994A1 (en) | 1997-02-12 |
| HU9602174D0 (en) | 1996-10-28 |
| HUT75236A (en) | 1997-04-28 |
| EP0757994B1 (en) | 2003-09-03 |
| JP3699482B2 (ja) | 2005-09-28 |
| US20020165358A1 (en) | 2002-11-07 |
| DK0757994T3 (da) | 2004-01-19 |
| KR100294328B1 (ko) | 2001-09-17 |
| NO319022B1 (no) | 2005-06-06 |
| FI963313A0 (sv) | 1996-08-26 |
| KR970701206A (ko) | 1997-03-17 |
| DE69531673D1 (de) | 2003-10-09 |
| HU220167B (hu) | 2001-11-28 |
| ZA9510982B (en) | 1996-08-22 |
| EP1275718A2 (en) | 2003-01-15 |
| NZ298142A (en) | 1997-08-22 |
| US6399744B1 (en) | 2002-06-04 |
| NO963552D0 (no) | 1996-08-26 |
| ES2206523T3 (es) | 2004-05-16 |
| AU4355196A (en) | 1996-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0733067T3 (da) | N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder | |
| PH22461A (en) | Preparation of functional human urokinase protein | |
| AU8502198A (en) | Method for treating vascular proliferative diseases with p27 and fusions thereof | |
| DK0757994T3 (da) | TCF-mutanter | |
| CA2509508A1 (en) | Tcf mutant | |
| DK0667872T3 (da) | Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6 | |
| ES2120958T3 (es) | Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion. | |
| EP0386240A4 (en) | Novel polypeptide compounds | |
| HK50993A (en) | Low affinity mutant hemoglobins and wholly artificial hemoglobins as blood substitutes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 116223 Country of ref document: FI |
|
| PC | Transfer of assignment of patent |
Owner name: ATLAS PHARMACEUTICALS INC. Free format text: ATLAS PHARMACEUTICALS INC. |